COVID-19 Survivorship Registry

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT04527315
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Questionnaires — OTHER
    Various questionnaires will be used to assess short and long-term impacts of depression, anxiety, and other indicators of overall mental health and quality of life

Study Details

COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.

Key Dates

Start date
Jul 17, 2020
Status verified
Oct 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: COVID-19 ICU Patients
  • Arm: Control

Primary Outcome Measure

Level of Inflammatory Markers [ Time Frame: Up to 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016
Ashley Witzl
[email protected]
212-263-1208
Daniel Walsh
[email protected]
929-573-0079
Rany Condos, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By condition
COVID-19 / long COVID
By specialty
Infectious disease
By research site
NYU Langone Health· New York, NY

Related Studies